IP Library Granted Patent US 9,968,125
Granted Patent B2
US 9,968,125 · App. 14/593,633 · Granted May 15, 2018

Nicotine—diketopiperazine microparticle formulations and methods of making the same

Inventors: Alex Stenzler (Long Beach, CA); Noe Zamel (Ontario, CA); Arthur Slutsky (Ontario, CA); Steven Ellis (Ontario, CA)
Assignee: Philip Morris Products S.A.
A24B15/16A24F47/002A61K31/465A61K9/1694A61K9/5084A61K31/495
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,968,125
App. No.
14/593,633
Granted
May 15, 2018
Kind
B2
Abstract

This invention relates to nicotine microparticles formulations made with the help of a diketopiperazine compound, in particular fumaryl diketopiperazine (FDKP). The invention relates to the various types of microparticles that can be made, in particular nicotine-coated and nicotine-loaded microparticles. The invention further relates to the various methods that can be used in making the microparticles. One particular method involves making FDKP microparticles which are further surface-coated with nicotine. Another particular method involves mixing nicotine with FDKP 2− and/or FDKP and then forming microparticles which contain nicotine throughout their volume. The invention also relates to the use of this microparticles in tobacco related therapies, such as tobacco replacement or tobacco withdrawal.

Claims (9)

1. A particulate formulation comprising nicotine and a diketopiperazine, wherein the diketopiperazine is fumaryl diketopiperazine(FDKP).

2. The formulation of claim 1 , wherein the formulation is suitable for inhalation.

3. The formulation of claim 1 , wherein the FDKP is in the anionic form of FDKP 2− .

4. The formulation of claim 1 , wherein the formulation comprises nicotine-coated particles.

5. The formulation of claim 1 , wherein the formulation comprises nicotine-loaded particles.

6. The formulation of claim 1 , further comprising a cough suppressant.

7. The formulation of claim 1 , further comprising a flavoring component.

8. The formulation of claim 1 , wherein the formulation comprises particles that are substantially spherical.

9. The formulation of claim 1 , wherein the formulation comprises particles that have a dimpled surface.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2020
From: SANSA CORPORATION
To: NICO PUFF CORPORATION
Reel/Frame 052353/0260 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2020
From: NICO PUFF CORPORATION
To: PHILIP MORRIS PRODUCTS S.A.
Reel/Frame 052353/0382 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2018
From: STENZLER, ALEX; ZAMEL, NOE; SLUTSKY, ARTHUR; ELLIS, STEVEN
To: SANSA CORPORATION (BARBADOS) INC
Reel/Frame 045503/0600 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2018
From: SANSA CORPORATION (BARBADOS) INC.
To: NICO PUFF CORPORATION
Reel/Frame 045510/0804 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2018
From: NICO PUFF CORPORATION
To: PHILIP MORRIS PRODUCTS S.A.
Reel/Frame 045510/0824 →
Continuity (1)
Related Publication 20160198758A1 · Jul 14, 2016